Investing.com - Innoviva reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Innoviva announced earnings per share of $2.80 on revenue of $67.26M. Analysts polled by Investing.com anticipated EPS of $2.21 on revenue of $200.48M.
Innoviva shares are up 86.39% from the beginning of the year, still down 37.60% from its 52 week high of $20.71 set on April 5.
Innoviva follows other major Healthcare sector earnings this month
Innoviva's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar